Biotecnol, Digna Biotech preclinical data

In rabbit models of fulminant hepatitis, CT-1 improved survival rates vs. control at 36 hours post-infection (100% vs. 55%) and at 60 hours post infection (80% vs. 18%). At 168 hours post-infection, 3...